CoChat

The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease: An emerging field

Polyzos, K. A., Ketelhuth, D. F. J. · 2015 · Hämostaseologie
Cited by 94

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Summary: Coronary heart disease and stroke, the deadliest forms of cardiovascular disease (CVD), are mainly caused by atherosclerosis, a chronic inflammatory disease of the artery wall driven by maladaptive immune responses in the vessel wall. Various risk factors for CVD influence this pathogenic process, including diabetes mellitus, hypertension, dyslipidaemia, and obesity. Indoleamine 2,3-dioxygenase (IDO), an enzyme catalyzing the rate-limiting step in the kynurenine pathway of tryptophan degradation, is strongly induced by inflammation in several tissues, including the artery wall. An increasing body of evidence indicates that IDO promotes immune tolerance, decreases inflammation, and functions as a homeostatic mechanism against excessive immune reactions. This review provides an overview of the emerging field of the kynurenine pathway of tryptophan degradation in CVD, emphasizing the role of IDO-mediated tryptophan metabolism and its metabolites in the modulation of ‘classical’ cardiovascular risk factors, such as hypertension, obesity, lipid metabolism, diabetes mellitus, and in the development of atherosclerotic CVD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5482/hamo-14-10-0052

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 93

  1. 10.2174/1381612811319330003 · DOI
  2. 10.1160/TH11-05-0321 · DOI
  3. 10.1084/jem.20092243 · DOI · Paper page
  4. 10.1016/j.imbio.2011.06.006 · DOI
  5. 10.1093/cvr/cvt033 · DOI · Paper page
  6. 10.4049/jimmunol.170.12.5809 · DOI · Paper page
  7. 10.1016/S0165-5728(02)00176-5 · DOI · Paper page
  8. 10.1186/ar2205 · DOI
  9. 10.1016/j.jaci.2007.11.021 · DOI
  10. 10.1053/j.gastro.2003.08.031 · DOI · Paper page
  11. 10.1016/S0021-9150(99)00011-8 · DOI · Paper page
  12. 10.1128/IAI.70.7.3959-3961.2002 · DOI · Paper page
  13. 10.1046/j.1440-1711.2003.t01-1-01177.x · DOI · Paper page
  14. 10.1515/bchm2.1936.243.6.237 · DOI
  15. Yamamoto, 1967, J Biol Chem, 242, 5260, 10.1016/S0021-9258(18)99420-2 · DOI · Paper page
  16. Werner-Felmayer, 1990, Cancer Res, 50, 2863
  17. 10.1016/j.coph.2003.10.006 · DOI · Paper page
  18. 10.1254/jjp.71.183 · DOI · Paper page
  19. Parsons, 1997, J Pharmacol Exp Thera, 283, 1264, 10.1016/S0022-3565(24)37160-5 · DOI · Paper page
  20. Hilmas, 2001, J Neurosci, 21, 7463, 10.1523/JNEUROSCI.21-19-07463.2001 · DOI · Paper page
  21. 10.1093/schbul/sbq002 · DOI · Paper page
  22. 10.1016/S0304-3940(01)02242-X · DOI · Paper page
  23. 10.1111/j.1471-4159.1991.tb03460.x · DOI · Paper page
  24. 10.1038/nrd870 · DOI · Paper page
  25. 10.1126/science.281.5380.1191 · DOI · Paper page
  26. 10.1084/jem.189.9.1363 · DOI · Paper page
  27. 10.1046/j.1365-2567.2002.01526.x · DOI · Paper page
  28. 10.1016/j.immuni.2005.03.013 · DOI · Paper page
  29. 10.1172/JCI200421583 · doi:10.1172/jci200421583 · Paper page
  30. 10.1084/jem.20020052 · DOI · Paper page
  31. 10.1038/sj.cdd.4401073 · DOI · Paper page
  32. 10.1165/rcmb.2011-0438OC · DOI
  33. 10.1002/jcb.21384 · DOI
  34. 10.1016/j.imlet.2010.05.008 · DOI
  35. 10.4049/jimmunol.0903670 · DOI · Paper page
  36. 10.1038/ni.2077 · DOI · Paper page
  37. 10.1038/nm.2092 · DOI · Paper page
  38. Changsirivathanathamrong, 2011, Crit Care Med, 39, 2678, 10.1097/CCM.0b013e31822827f2 · DOI
  39. 10.1081/CEH-100106826 · doi:10.1081/ceh-100106826
  40. 10.1161/01.HYP.35.1.413 · DOI
  41. 10.1074/jbc.C200303200 · DOI
  42. 10.1111/j.1440-1681.1994.tb02460.x · DOI
  43. 10.1291/hypres.25.135 · DOI
  44. 10.1172/JCI200319451 · DOI · Paper page
  45. 10.1080/00365510802245685 · DOI · Paper page
  46. 10.1111/j.1365-2249.2007.03325.x · DOI · Paper page
  47. 10.1002/oby.20491 · DOI · Paper page
  48. 10.1152/ajpregu.00373.2011 · DOI · Paper page
  49. 10.1371/journal.pone.0073404 · DOI
  50. 10.1016/j.cmet.2012.04.001 · DOI · Paper page
  51. 10.1093/eurheartj/ehs175 · DOI · Paper page
  52. 10.4161/cbt.12.12.18142 · DOI
  53. Oxenkrug, 2013, Hepat Res Treat, 2013, 149247
  54. 10.3109/13813455.2011.623705 · DOI
  55. Hattori, 1984, Acta Vitaminol Enzymol, 6, 221
  56. 10.1007/BF02355886 · DOI
  57. 10.1074/jbc.M109.087338 · DOI · Paper page
  58. Kotake, 1975, Acta Vitaminol Enzymol, 29, 236
  59. 10.1166/ajnn.2011.1024 · DOI
  60. 10.3945/ajcn.2009.28571 · DOI
  61. 10.1007/s12035-013-8497-4 · DOI · Paper page
  62. 10.4049/jimmunol.0901577 · DOI
  63. Okamoto, 1983, Princess Takamatsu Symp, 13, 297
  64. 10.2337/diabetes.51.2.356 · DOI · Paper page
  65. 10.1038/ni846 · DOI · Paper page
  66. 10.1371/journal.pone.0071044 · DOI
  67. 10.2337/db06-0617 · DOI · Paper page
  68. 10.1016/j.ijcard.2012.12.090 · DOI
  69. 10.1161/ATVBAHA.110.219329 · DOI · Paper page
  70. 10.1046/j.1365-2362.2003.01186.x · DOI · Paper page
  71. 10.1111/j.1542-4758.2010.00464.x · DOI
  72. 10.1161/CIRCULATIONAHA.106.666511 · DOI
  73. 10.1016/j.atherosclerosis.2008.08.014 · DOI
  74. 10.1016/j.clinbiochem.2010.06.008 · doi:10.1016/j.clinbiochem.2010.06.008
  75. 10.2478/v10039-010-0015-6 · DOI
  76. 10.1016/j.atherosclerosis.2008.10.002 · DOI
  77. 10.3109/07853890903321559 · DOI
  78. 10.4049/jimmunol.179.8.5246 · DOI · Paper page
  79. 10.1161/ATVBAHA.111.229443 · DOI · Paper page
  80. 10.1161/CIRCRESAHA.111.256529 · DOI
  81. 10.1172/JCI117211 · DOI
  82. 10.1016/j.atherosclerosis.2005.09.010 · DOI
  83. 10.1007/s11064-010-0187-2 · DOI
  84. 10.1111/j.1460-9568.2007.05838.x · DOI · Paper page
  85. 10.1186/1742-2094-8-17 · DOI · Paper page
  86. 10.1007/s00210-011-0611-4 · DOI
  87. 10.1016/S0165-6147(00)01451-6 · DOI · Paper page
  88. 10.1016/j.ejphar.2011.05.069 · DOI
  89. 10.1038/jcbfm.1992.57 · DOI · Paper page
  90. 10.1016/j.nbd.2008.07.013 · DOI
  91. 10.1016/j.ejphar.2007.02.029 · DOI
  92. Moroni F, Cozzi A, Peruginelli F et al. Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia. Adv Exp Med Biol 1999; 467: 199-206. E · DOI
  93. 10.1016/j.neuroscience.2013.04.063 · DOI

Cited by

See all 94

Metadata

Authors
Polyzos, K. A., & Ketelhuth, D. F. J.
Venue
Hämostaseologie
Published
2015
Volume
35
Issue
02
Pages
128-136
ISSN
  • 0720-9355 (ISSN-L)
  • 2567-5761
OpenAlex
W2135674854
Cited by
94
References
7
FWCI
2.52
Type
journal article
Language
de
Open access
closed
Funders
  • Swedish Heart-Lung Foundation
  • Karolinska Institute Cardiovascular Program Career Development
  • Åke Wibergs Stiftelse
  • Stiftelsen för Gamla Tjänarinnor
  • Stiftelsen Professor Nanna Svartz fond
  • KI fond
  • Alexander S. Onassis Public Benefit Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease: An emerging field. https://app.cochat.ai/papers/10.5482/hamo-14-10-0052
The paper
Polyzos, K. A., & Ketelhuth, D. F. J. (2015). The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease: An emerging field. Hämostaseologie. https://doi.org/10.5482/hamo-14-10-0052

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.